Active ingredientVicrivirocCat. No. P-V037-001CAS 306296-47-9Family · Pharmaceutical analytical standards
Vicriviroc
An oral CCR5 receptor antagonist, studied in the 2000s against HIV to stop the virus from entering cells. It reached phase III, but in 2010 it was not submitted for approval. This family brings together the active ingredient and labelled standards.
Did you know?The idea came from a 1996 discovery: people who inherit two copies of the CCR5-delta32 gene variant have no working CCR5 receptors and are highly resistant to HIV infection.
Go to the active ingredient →Active ingredientVicrivirocCat. No. P-V037-001CAS 306296-47-9
Isotopically labelledVicriviroc-13C-d3Cat. No. P-V037-002No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.